Fig 8.
Model depicting the role of cytokine-mediated SRSF1 upregulation as a BCR-ABL1-independent mechanism that impairs imatinib sensitivity in CP progenitor cells, and enables enhanced survival and persistence.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.